Additional European Equity News

ASR Nederland (ASRNL NA) - Board intends to appoint Ingrid De Swart as CEO and new Chair of the executive board. (Newswires) 

Aston Martin (AML LN) - Trading Update (GBP): Co. cuts FY2025 outlook, FY2025 wholesale volumes to decline Y/Y and no longer expects positive free cash flow in H2 2025. Cuts Q3 Wholesale Units 1.4k (prev. 1.6k Y/Y). Expects EBIT to now be at the lower end of the market consensus. Cuts FY25 Capex 375mln (prev. guided 400mln). Notes that an immediate revise of future cost and capital expenditures has been initiated. (Aston Martin)

Astrazeneca (AZN LN) - Co. reports improved overall survival and progression-free survival for patients using Datroway as first-line treatment for TROPION-Breast02. (Astrazeneca)

Hiscox (HSX LN) - Co. launches the second tranche of its share repurchase programme. (Hiscox)

Mondi (MNDI LN) - Q3 Trading Update (GBP): Underlying EBITDA 223mln (prev. 274mln Q/Q); Forestry fair value gain 20mln (prev. 16mln Y/Y). Notes of a challenging trading environment on a quarterly basis. "Volumes were impacted by subdued demand and paper selling prices declined during the quarter". (Mondi) 

Saint Gobain (SGO FP) - Sees EBITDA Margin between 15-18% in 2026-2030. (Saint Gobain) 

06 Oct 2025 - 07:15- EquitiesEU Research- Source: Newsquawk